Search Results - "Sayler, Mary E."

Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: The absence of an effect related to agitation and suicidal behavior by Wernicke, Joachim F., Sayler, Mary E., Koke, Stephanie C., Pearson, Donna K., Tollefson, Gary D.

“…Concomitant use of psychoactive medications is a common practice in most clinical trials of antidepressant medications. However, the relative therapeutic…”
Get full text

Course of psychomotor agitation during pharmacotherapy of depression: Analysis from double-blind controlled trials with fluoxetine by Tollefson, Gary D., Sayler, Mary E.

“…Psychomotor agitation, a common clinical feature of major depression, may first emerge or intensify during pharmacotherapy. Whether agitation is part of the…”
Get full text

Fluoxetine and suicide : a meta-analysis of controlled trials of treatment for depression by BEASLEY, C. M, DORNSEIF, B. E, BOSOMWORTH, J. C, SAYLER, M. E, RAMPEY, A. H, HEILIGENSTEIN, J. H, THOMPSON, V. L, MURPHY, D. J, MASICA, D. N

Get full text

Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: a comparative trial of fluoxetine versus imipramine by Tollefson, G D, Greist, J H, Jefferson, J W, Heiligenstein, J H, Sayler, M E, Tollefson, S L, Koback, K

“…A common presentation for major depression includes psychomotor agitation. However, this subtype has been the infrequent subject of controlled investigation…”
Get more information

Fluoxetine: activating and sedating effects at multiple fixed doses by Beasley, Jr, C M, Sayler, M E, Weiss, A M, Potvin, J H

“…Serotonin uptake inhibitors are generally considered activating antidepressants. To assess rates and temporal patterns of activation and sedation as well as…”
Get more information

Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxiety by SMITH, W. T, LONDBORG, P. D, BLOMGREN, S. L, TOLLEFSON, G. D, SAYLER, M. E

“…The aim of this study was to make a preliminary investigation of the efficacy and safety of zatosetron maleate, a selective 5-hydroxytryptamine-3 receptor…”
Get full text

High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression by Beasley, Jr, C M, Sayler, M E, Bosomworth, J C, Wernicke, J F

“…The effects of high-dose fluoxetine (median 80 mg/day), standard-dose imipramine (median 200 mg/day), and placebo were studied in 706 outpatients meeting…”
Get more information

Fluoxetine in tricyclic refractory major depressive disorder by Beasley, Jr, C M, Sayler, M E, Cunningham, G E, Weiss, A M, Masica, D N

“…Data regarding open-label treatment with fluoxetine following failure to respond to tricyclic antidepressants (TCAs) or intolerance of TCA side effects,…”
Get more information

Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders by Tollefson, G D, Fawcett, J, Winokur, G, Beasley, Jr, C M, Potvin, J H, Faries, D E, Rampey, Jr, A H, Sayler, M E

“…Double-blind, controlled clinical trial data were evaluated to assess a hypothetical relationship between fluoxetine and suicidality (suicidal acts and…”
Get more information

Analysis of mortality in pergolide-treated patients with Parkinson's disease by Sayler, M E, Street, J S, Bosomworth, J C, Potvin, J H, Kotsanos, J G

“…Parkinson's disease, because of its progressive degenerative nature, is associated with increased disability and mortality compared with mortality in the…”
Get more information

Efficacy and Safety of Long‐Term Fluoxetine Treatment of Obesity ‐ Maximizing Success by Goldstein, David J., Rampey, Alvin H., Roback, Paul J., Wilson, Michael G., Hamilton, Susan H., Sayler, Mary E., Tollefson, Gary D.

“…Obesity is a major health care concern because of its associated medical complications and increased mortality. Despite a myriad of short‐term weight loss…”
Get full text

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression by Beasley, C M, Dornseif, B E, Bosomworth, J C, Sayler, M E, Rampey, A H, Heiligenstein, J H, Thompson, V L, Murphy, D J, Masica, D N

“…OBJECTIVE--A comprehensive meta-analysis of clinical trial data was performed to assess the possible association of fluoxetine and suicidality (suicidal acts…”
Get full text